UCB S.A. revenue breakdown overview

UCB S.A. revenue for the last year amounted to 5.69 B USD, the most of which — 5.26 B USD — came from its highest performing source at the moment, Biopharmaceuticals, the year earlier bringing 5.40 B USD. The greatest contribution to the revenue figure was made by United States — last year it brought UCB S.A. 2.65 B USD, and the year before that — 3.05 B USD.